Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0190 EUR
−4.32 M EUR
3.05 M EUR
191.84 M
About IMMURON LIMITED
Sector
CEO
Steven Lydeamore
Headquarters
Blackburn North
Website
Founded
1994
ISIN
AU000000IMC7
FIGI
BBG000FG8ZS1
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce on mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994, and is headquartered in Carlton, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IMMURON LTD stocks are traded under the ticker ANW.
We've gathered analysts' opinions on IMMURON LTD future price: according to them, ANW price has a max estimate of 0.12 EUR and a min estimate of 0.12 EUR. Watch ANW chart and read a more detailed IMMURON LTD stock forecast: see what analysts think of IMMURON LTD and suggest that you do with its stocks.
Yes, you can track IMMURON LTD financials in yearly and quarterly reports right on TradingView.
IMMURON LTD is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ANW net income for the last half-year is −3.03 M EUR, while the previous report showed −1.28 M EUR of net income which accounts for −136.71% change. Track more IMMURON LTD financial stats to get the full picture.
No, ANW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ANW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMURON LTD stock right from TradingView charts — choose your broker and connect to your account.